Fingerprint
Dive into the research topics of 'Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies
Ruben A. Mesa, Stacie Hudgens, Lysbeth Floden, Claire N. Harrison, Jeanne Palmer, Vikas Gupta, Donal P. McLornan, Mary F. McMullin, Jean Jaques Kiladjian, Lynda Foltz, Uwe Platzbecker, M. Laura Fox, Adam J. Mead, David M. Ross, Stephen T. Oh, Andrew Perkins, Michael F. Leahy, Samineh Deheshi, Rafe Donahue, Barbara J. Klencke
- Department of Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Cancer Biology
- DBBS - Immunology
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- Division of Hematology
- Institute of Clinical and Translational Sciences (ICTS)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Rheumatic Diseases Research Resource-Based Center
- Siteman Cancer Center
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations